The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Delivery Systems Market Research Report 2025
Synopsis
Drug Delivery includes formulations, technologies, methods, and systems for transferring an active pharmaceutical ingredients into the body to safely provide therapeutic effect.
The global Drug Delivery Systems market was valued at US$ 499770 million in 2023 and is anticipated to reach US$ 673940 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery Systems.
Report Scope
The Drug Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Amgen
Roche
Pfizer
Johnson & Johnson
Becton Dickinson
AstraZeneca
Baxter
Bayer
Boston Scientific
Segment by Type
Intrauterine Implants
Prodrug Implants
Polymeric Drug Delivery
Targeted Drug Delivery
Others
Segment by Application
Cardiovascular Diseases
Oncology
Urology
Diabetes
CNS
Ophthalmology
Infections
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Delivery Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Drug Delivery includes formulations, technologies, methods, and systems for transferring an active pharmaceutical ingredients into the body to safely provide therapeutic effect.
The global Drug Delivery Systems market was valued at US$ 499770 million in 2023 and is anticipated to reach US$ 673940 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery Systems.
Report Scope
The Drug Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Amgen
Roche
Pfizer
Johnson & Johnson
Becton Dickinson
AstraZeneca
Baxter
Bayer
Boston Scientific
Segment by Type
Intrauterine Implants
Prodrug Implants
Polymeric Drug Delivery
Targeted Drug Delivery
Others
Segment by Application
Cardiovascular Diseases
Oncology
Urology
Diabetes
CNS
Ophthalmology
Infections
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Delivery Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Delivery Systems Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Intrauterine Implants
1.2.3 Prodrug Implants
1.2.4 Polymeric Drug Delivery
1.2.5 Targeted Drug Delivery
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drug Delivery Systems Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cardiovascular Diseases
1.3.3 Oncology
1.3.4 Urology
1.3.5 Diabetes
1.3.6 CNS
1.3.7 Ophthalmology
1.3.8 Infections
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Delivery Systems Market Perspective (2019-2030)
2.2 Drug Delivery Systems Growth Trends by Region
2.2.1 Global Drug Delivery Systems Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Delivery Systems Historic Market Size by Region (2019-2024)
2.2.3 Drug Delivery Systems Forecasted Market Size by Region (2025-2030)
2.3 Drug Delivery Systems Market Dynamics
2.3.1 Drug Delivery Systems Industry Trends
2.3.2 Drug Delivery Systems Market Drivers
2.3.3 Drug Delivery Systems Market Challenges
2.3.4 Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Delivery Systems Players by Revenue
3.1.1 Global Top Drug Delivery Systems Players by Revenue (2019-2024)
3.1.2 Global Drug Delivery Systems Revenue Market Share by Players (2019-2024)
3.2 Global Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Delivery Systems Revenue
3.4 Global Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Delivery Systems Revenue in 2023
3.5 Drug Delivery Systems Key Players Head office and Area Served
3.6 Key Players Drug Delivery Systems Product Solution and Service
3.7 Date of Enter into Drug Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Delivery Systems Breakdown Data by Type
4.1 Global Drug Delivery Systems Historic Market Size by Type (2019-2024)
4.2 Global Drug Delivery Systems Forecasted Market Size by Type (2025-2030)
5 Drug Delivery Systems Breakdown Data by Application
5.1 Global Drug Delivery Systems Historic Market Size by Application (2019-2024)
5.2 Global Drug Delivery Systems Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Delivery Systems Market Size (2019-2030)
6.2 North America Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Delivery Systems Market Size by Country (2019-2024)
6.4 North America Drug Delivery Systems Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Delivery Systems Market Size (2019-2030)
7.2 Europe Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Delivery Systems Market Size by Country (2019-2024)
7.4 Europe Drug Delivery Systems Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery Systems Market Size (2019-2030)
8.2 Asia-Pacific Drug Delivery Systems Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Delivery Systems Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Delivery Systems Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Delivery Systems Market Size (2019-2030)
9.2 Latin America Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Delivery Systems Market Size by Country (2019-2024)
9.4 Latin America Drug Delivery Systems Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Delivery Systems Market Size (2019-2030)
10.2 Middle East & Africa Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Delivery Systems Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Delivery Systems Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Drug Delivery Systems Introduction
11.1.4 Novartis Revenue in Drug Delivery Systems Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Drug Delivery Systems Introduction
11.2.4 Amgen Revenue in Drug Delivery Systems Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Drug Delivery Systems Introduction
11.3.4 Roche Revenue in Drug Delivery Systems Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Drug Delivery Systems Introduction
11.4.4 Pfizer Revenue in Drug Delivery Systems Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Drug Delivery Systems Introduction
11.5.4 Johnson & Johnson Revenue in Drug Delivery Systems Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Detail
11.6.2 Becton Dickinson Business Overview
11.6.3 Becton Dickinson Drug Delivery Systems Introduction
11.6.4 Becton Dickinson Revenue in Drug Delivery Systems Business (2019-2024)
11.6.5 Becton Dickinson Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Drug Delivery Systems Introduction
11.7.4 AstraZeneca Revenue in Drug Delivery Systems Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 Baxter
11.8.1 Baxter Company Detail
11.8.2 Baxter Business Overview
11.8.3 Baxter Drug Delivery Systems Introduction
11.8.4 Baxter Revenue in Drug Delivery Systems Business (2019-2024)
11.8.5 Baxter Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Drug Delivery Systems Introduction
11.9.4 Bayer Revenue in Drug Delivery Systems Business (2019-2024)
11.9.5 Bayer Recent Development
11.10 Boston Scientific
11.10.1 Boston Scientific Company Detail
11.10.2 Boston Scientific Business Overview
11.10.3 Boston Scientific Drug Delivery Systems Introduction
11.10.4 Boston Scientific Revenue in Drug Delivery Systems Business (2019-2024)
11.10.5 Boston Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
